Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
Abroad (travel likely)RecruitingPHASE3
Conditions
Sickle Cell Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Site # 8400006, Atlanta, Georgia, United States
Site # 8400002, Atlanta, Georgia, United States
Site # 8400003, Omaha, Nebraska, United States
Site # 8400001, New Brunswick, New Jersey, United States
Site # 8400004, Houston, Texas, United States
Site # 2140001, Santo Domingo, Dominican Republic
Site # 2140003, Santo Domingo, Dominican Republic
Study leads
Clinical Sciences & Operations Study Director
Study Director
Sanofi